Making the Complex Seamless® in Psychiatry Clinical Development
Developing effective treatments for psychiatric disorders such as depression, bipolar disorder, anxiety disorders, PTSD, and schizophrenia requires a clinical research organization (CRO) partner with the specialized expertise and relevant experience to effectively address the unique challenges involved.
Streamline and accelerate your clinical research in psychiatry with support from our experienced, cross-functional team of medical and regulatory experts, clinical trial management teams, central labs, and core imaging labs. As a full-service and therapeutically-focused CRO with a unique approach to clinical development, Medpace specializes in the design and conduct of the most complex and challenging global trials in neuroscience clinical research, including psychiatry.
The Medpace Advantage
Gain a competitive advantage for your program through our global footprint, strategic medical, regulatory, and operational leadership as well as fully integrated Central Labs and Core Imaging services to accelerate psychiatric studies.
Psychiatry Clinical Research Capabilities
Partner with a global CRO with a cross-functional collaborative model to position your psychiatric clinical trial for success. The Medpace neuroscience team can support your clinical trials through:
- In-depth knowledge of screening tools and rater scales and experience providing oversight for rater services including subjective assessments, inter-rater reliability, and scale validation
- Broad neuroscience experience and long-term relationships with experienced sites, networks, and key opinion leaders (KOLs) worldwide, providing access to the best sites for your specific program
- A proprietary feasibility strategy and dedicated in-house recruitment and retention team deliver custom-tailored recruitment strategies to support the unique needs of each psychiatry trial
- Placebo mitigation strategies to limit the potential for placebo response through site and participant education
- Detailed knowledge of regulatory requirements for managing studies utilizing controlled substances, including DEA Schedule I investigational products
Integrated Services
Streamline complex neuropsychiatry clinical trials with a full-service, single-vendor outsourcing strategy. Our comprehensive CRO services are supported by our wholly-owned Central Laboratories, Bioanalytical Lab, Imaging and ECG Core Lab, and Phase I Unit, as well as a Clinical Trial Management System, including eDiary and ePRO, that ties all study data together in a single platform.
Central Lab Capabilities
Medpace Central Labs offer comprehensive global lab services during all stages of the development process. Focused on both the scientific and service aspects with wholly-owned laboratories in the US, Europe, China, and Singapore, our central laboratories have the geographic reach to support global studies, assist with regulatory requirements, and deliver custom solutions for any need.
Specialized Imaging for Your Psychiatric Programs
The complexities of mental health research require a heightened level of integration and efficiency. Through its wholly-owned subsidiaries, Medpace provides an end-to-end suite of imaging services to enhance and expedite biopharmaceutical and imaging contrast agent development through its Imaging Core Lab. Capabilities include:
- Standard diagnostic imaging
- Magnetic resonance imaging (MRI)
- Computed tomography (CT)
- Bone densitometry or dual-energy x-ray absorptiometry (DXA)
Psychiatry Trial Experts
Serving as therapeutic team leaders, our in-house medical doctors apply years of psychiatric drug development experience to each study, providing greater depth of expertise and the ability to tackle complex and challenging diseases. Our medical leaders are at the center of your trials to provide strategic direction for study design and planning, train operational staff, work with Investigators, provide medical monitoring, and meet with regulatory agencies as well as our global regulatory affairs experts to provide strategic guidance into the best pathways to accelerate approvals.
Key Psychiatry Indications
Medpace medical, regulatory, and operational experts bring a broad range of experience in designing and conducting psychiatric studies spanning adult and pediatric populations, including rare disease and orphan indications. Areas of focus include:
- Addictive Disorders – Substance Use Disorders
- Anxiety Disorders
- Attention-Deficit/Hyperactivity Disorder
- Autism Spectrum Disorder
- Bipolar Disorder
- Cognition Disorders
- Developmental Disorders
- Eating Disorders
- Major Depressive Disorder
- Neuropsychiatric Disorders
- Post Traumatic Stress Disorder
- Postpartum Depression
- Schizophrenia
- Sleep Disorders
- Narcolepsy
- Idiopathic Hypersomnia
- Circadian Rhythm Disorders
